NOVARTIS PHARMA AG's Net Worth
$1.44 Billion
Who is NOVARTIS PHARMA AG?
NOVARTIS PHARMA AG has an estimated net worth of $1.44 Billion. This is based on reported shares across multiple companies, which include REGENERON PHARMACEUTICALS INC, Cellular Biomedicine Group, Inc., Poseida Therapeutics, Inc., ALNYLAM PHARMACEUTICALS, INC., IDENIX PHARMACEUTICALS INC, and PRECISION BIOSCIENCES INC.
SEC CIK
NOVARTIS PHARMA AG's CIK is 0001030617
Past Insider Trading and Trends
2012 was NOVARTIS PHARMA AG's most active year for acquiring shares with 19 total transactions. NOVARTIS PHARMA AG's most active month to acquire stocks was the month of January. 2005 was NOVARTIS PHARMA AG's most active year for disposing of shares, totalling 1 transactions. NOVARTIS PHARMA AG's most active month to dispose stocks was the month of June. 2005 saw NOVARTIS PHARMA AG paying a total of $105,141,026.65 for 5,126,224 shares, this is the most they've acquired in one year. In 2014 NOVARTIS PHARMA AG cashed out on 33,320,674 shares for a total of $816,356,513.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
REGENERON PHARMACEUTICALS INC (REGN) Snapshot price: $941
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -7.53M |
$11.06 | -$83,249,173.00 |
0
|
Nov 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cellular Biomedicine Group, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Poseida Therapeutics, Inc. (PSTX) Snapshot price: $3.405
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.91M |
—
|
—
| 5.91M |
Jul 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALNYLAM PHARMACEUTICALS, INC. (ALNY) Snapshot price: $169.09
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -27.70% | -1.55M |
$19.42 | -$30,137,820.32 | 4.05M |
Sep 20
| |||
Form 4
| +1.00% | 55.22K |
$17.99 | $993,461.77 | 5.6M |
Apr 23
| |||
Form 4
| +1.20% | 65.92K |
$17.50 | $1,153,635.00 | 5.55M |
May 6
| |||
Form 4
| +4.06% | 213.89K |
$25.29 | $5,409,227.52 | 5.48M |
May 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IDENIX PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -33.32M |
$24.50 | -$816,356,513.00 |
0
|
Aug 5
| |||
Form 4
| +0.26% | 84.89K |
$3.43 | $291,282.90 | 33.32M |
Feb 23
| |||
Form 4/A
| +0.04% | 26.76K |
$3.83 | $114,522.56 | 66.43M |
Nov 22
| |||
Form 4
| +0.08% | 50.53K |
$3.80 | $206,400.37 | 66.44M |
Nov 22
| |||
Form 4
| +5.69% | 1.79M |
$2.80 | $4,999,999.20 | 33.19M |
Apr 13
| |||
Form 4
| +0.02% | 20.99K |
$3.41 | $55,416.68 | 94.19M |
Feb 25
| |||
Form 4
| +0.02% | 17.08K |
$3.49 | $46,689.69 | 94.13M |
Nov 26
| |||
Form 4/A
| +0.12% | 37.21K |
$2.45 | $91,009.11 | 31.36M |
Aug 13
| |||
Form 4
| +0.04% | 37.21K |
$3.08 | $91,009.11 | 94.08M |
Aug 23
| |||
Form 4
| +0.00% | 1.35K |
$2.41 | $3,255.91 | 31.32M |
Jun 8
| |||
Form 4
| +0.01% | 1.87K |
$2.41 | $4,511.52 | 31.32M |
Feb 26
| |||
Form 4/A
| +0.01% | 3.57K |
$2.41 | $8,606.11 | 31.32M |
Aug 21
| |||
Form 4
| +0.01% | 3.43K |
$2.41 | $8,268.71 | 31.32M |
Aug 21
| |||
Form 4
| +0.01% | 2.45K |
$2.62 | $6,421.62 | 31.32M |
May 29
| |||
Form 4
| +0.02% | 5.44K |
$2.41 | $13,120.04 | 31.31M |
Feb 23
| |||
Form 4
| +0.02% | 4.75K |
$4.05 | $19,225.35 | 31.31M |
Nov 19
| |||
Form 4
| +0.01% | 4.65K |
$2.93 | $13,636.22 | 31.3M |
Sep 2
| |||
Form 4
| +0.00% | 924 |
$2.41 | $2,226.84 | 31.3M |
May 29
| |||
Form 4
| +0.00% | 365 |
$20.48 | $7,475.20 | 31.3M |
Jun 6
| |||
Form 4
| +0.01% | 2.94K |
$16.23 | $47,683.74 | 31.3M |
Apr 4
| |||
Form 4
| +14.40% | 3.94M |
$20.61 | $81,185,489.91 | 31.3M |
Oct 31
| |||
Form 4
| +4.54% | 1.19M |
$20.18 | $23,955,536.74 | 27.36M |
Sep 2
| |||
Form 4
| +13.48% | 6.5M |
$14.00 | $75,600,000.00 | 54.71M |
Jul 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||